A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
A. BUSINESS DEVELOPMENT There have been no changes to our business development since our last annual report on Form 10-K. We are still in the start-up stage and have not commenced operations. B. FINANCIAL INFORMATION ABOUT SEGMENTS As defined by generally accepted accounting principles ("GAAP"), we do not have any segments separate and apart from our business as a whole. Accordingly, there are no measures of revenue from external customers, profit and loss, or total assets aside from what is reported in the Financial Statements attached to this Form 10-K. C. BUSINESS OF THE COMPANY HST Global, Inc. (the “ Company”) was founded as an integrated health and wellness biotechnology company with a plan to develop and /or acquire a network of wellness centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer. To date we have been unable to initiate our original business plan.
| Metric | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -102K | -146K | -145K | -148K | -209K | 427K |
| EPS | $-0.01 | $-0.03 | $-0.03 | $-0.03 | $-0.04 | $0.13 |
| Free Cash Flow | 0 | -21K | -21K | -30K | -27K | -92K |
| ROIC | -6.4% | -7294.7% | -58640.9% | -51163.2% | -24894.3% | -7752.1% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | -1.00 | -0.17 | -0.18 | -0.17 | -1.57 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -98K | -141K | -141K | -146K | -208K | -152K |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -8.2% | - | - | - | - | - |
| Shares Outstanding | 43M | 5M | 5M | 5M | 5M | 3M |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | |||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 33K | 23K | 71K | 28K | 26K | 21K | 21K | 38K |
| EBIT | -153K | -143K | -152K | -208K | -146K | -141K | -141K | -98K |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -165K | -178K | 427K | -209K | -148K | -145K | -146K | -102K |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | N/M | N/A | N/M | N/M | N/M | N/M | N/M | -6.4% |
| ROE | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -8.2% |
| ROA | -43675.1% | N/A | 21819.5% | -15984.1% | -33527.7% | -69915.2% | -17040.8% | -7.9% |
| Cash Flow | ||||||||
| Op. Cash Flow | -30K | -21K | -92K | -27K | -30K | -21K | -21K | -38K |
| Free Cash Flow | -30K | -21K | -92K | -27K | -30K | -21K | -21K | 0 |
| Owner Earnings | -30K | -21K | -92K | -27K | -30K | -21K | -21K | -38K |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | 1.4M | 1.4M | N/A | 25K | 55K | 76K | N/A | -21K |
| Cash & Equiv. | 0 | 0 | 2K | 0 | 0 | 0 | 2K | 21K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | -0.42 | -0.41 | -1.57 | -0.17 | -0.18 | -0.17 | -1.00 | 0.00 |
| Interest Coverage | -4.3 | -4.0 | -8.5 | -205.1 | -55.2 | -34.9 | -26.6 | -26.6 |
| Equity | -3.2M | -3.4M | -3K | -152K | -301K | -446K | -592K | 1.2M |
| Total Assets | 0 | 0 | 2K | 0 | 0 | 0 | 2K | 1.3M |
| Total Liabilities | 3.2M | 3.4M | 5K | 153K | 301K | 446K | 594K | 42K |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.3M |
| Retained Earnings | -5.6M | -5.8M | -5.4M | -5.6M | -5.7M | -5.9M | -6.0M | -6.1M |
| Working Capital | -3.2M | N/A | -3K | -152K | -301K | -446K | -592K | -32K |
| Current Assets | 0 | 0 | 2K | 0 | 0 | 0 | 2K | 10K |
| Current Liabilities | 3.2M | 3.4M | 5K | 153K | 301K | 446K | 594K | 42K |
| Per Share Data | ||||||||
| EPS | 0.00 | -1.05 | 0.13 | -0.04 | -0.03 | -0.03 | -0.03 | -0.01 |
| Owner EPS | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Book Value | -1.30 | -1.38 | -0.00 | -0.03 | -0.06 | -0.09 | -0.12 | 0.03 |
| Cash Flow/Share | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 2.4M | 2.4M | 3.3M | 5.2M | 4.9M | 4.8M | 4.9M | 42.8M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | 1.1 | N/A | N/A | N/A | N/A | -62.5 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 21.6 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | -8.1% | -10.0% | -20.0% | -5.7% | -5.2% | -2.7% | -0.7% | N/A |
| Market Cap | 367K | 210K | 459K | 475K | 577K | 787K | 3.2M | 27M |
| Avg. Price | 0.10 | 0.10 | 0.13 | 0.09 | 0.11 | 0.14 | 0.25 | 0.63 |
| Year-End Price | 0.15 | 0.08 | 0.14 | 0.09 | 0.11 | 0.15 | 0.61 | 0.63 |
HST Global, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
At current prices, the estimated annualized return to fair value is -6.0%.
HST Global, Inc. (HSTC) has a market capitalization of $27M. It is classified as a small-cap stock.
HST Global, Inc. (HSTC) does not currently pay a regular dividend.
HST Global, Inc. (HSTC) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
HST Global, Inc. (HSTC) generated $-21 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
HST Global, Inc. (HSTC) reported earnings per share (EPS) of $-0.03 in its most recent fiscal year.
The Ledger Terminal provides 7 years of financial data for HST Global, Inc. (HSTC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
HST Global, Inc. (HSTC) has a book value per share of $-0.12, based on its most recent annual SEC filing.
No recent press releases.